Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Recurrent Urinary Tract Infection: later-stage trial registry
2 of 5 indexed Recurrent Urinary Tract Infection trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Recurrent Urinary Tract Infection: 5 US clinical trials tracked, 2 recruiting.
Recurrent Urinary Tract Infection is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Maimonides Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition recurrent-urinary-tract-infection
OPEN 2 | RECR 40% | LATE 4 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Recurrent Urinary Tract Infection lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Recurrent Urinary Tract Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Recurrent Urinary Tract Infection is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Recurrent Urinary Tract Infection research.
Maimonides Medical Center accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Recurrent Urinary Tract Infection enrolment sits around 100 participants.
Median target enrolment is 100 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Recurrent Urinary Tract Infection research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
Maimonides Medical Center
NCT04807894
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
University of Texas Southwestern Medical Center
NCT06940622
Chlorhexidine Lavage for Recurrent Urinary Tract Infection
Oregon Health and Science University
NCT06598514
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
University of California, Irvine
NCT06353269
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
Wake Forest University Health Sciences
NCT05723601
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Recurrent Urinary Tract Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Recurrent Urinary Tract Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Recurrent Urinary Tract Infection page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Recurrent Urinary Tract Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Maimonides Medical Center sponsors the most Recurrent Urinary Tract Infection trials on record, review their full trial history before evaluating a specific study. See Maimonides Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Recurrent Urinary Tract Infection condition card totals 5 registered trials; most-linked intervention Estradiol Vaginal Tablet; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.